1. |
Klein BE. Overview of epidemiologic studies of diabetic retinopathy[J]. Ophthalmic Epidemiol, 2007, 14(4): 179-183. DOI: 10.1080/09286580701396720.
|
2. |
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564. DOI: 10.2337/dc11-1909.
|
3. |
Boyer DS, Yoon YH, Belfort R, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema[J]. Ophthalmology, 2014, 121(10): 1904-1914. DOI: 10.1016/j.ophtha.2014.04.024.
|
4. |
Li X, Zhang P, Wang B, et al. NDRG1 negatively regulates proliferation and milk bio-synthesis of bovine epithelial cells via the mTOR signaling pathway[J]. Res Vet Sci, 2019, 124: 158-165. DOI: 10.1016/j.rvsc.2019.03.007.
|
5. |
Park KC, Paluncic J, Kovacevic Z, et al. Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer[J]. Free Radic Biol Med, 2020, 157: 154-175. DOI: 10.1016/j.freeradbiomed.2019.05.020.
|
6. |
Lin Y, Wang L, Luo W, et al. CYLD promotes apoptosis of nasopharyngeal carcinoma cells by regulating NDRG1[J]. Cancer Manag Res, 2020, 12: 10639-10649. DOI: 10.2147/CMAR.S268216.
|
7. |
Chekmarev J, Azad MG, Richardson DR. The oncogenic signaling disruptor, NDRG1: molecular and cellular mechanisms of activity[J]. Cells, 2021, 10(9): 2382. DOI: 10.3390/cells10092382.
|
8. |
Toffoli S, Delaive E, Dieu M, et al. NDRG1 and CRK-Ⅰ/Ⅱ are regulators of endothelial cell migration under intermittent hypoxia[J]. Angiogenesis, 2009, 12(4): 339-354. DOI: 10.1007/s10456-009-9156-2.
|
9. |
Dong L, Zhang Z, Liu X, et al. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy[J]. J Mol Med (Berl), 2021, 99(2): 225-240. DOI: 10.1007/s00109-020-01995-8.
|
10. |
Zhang Y, Lv X, Hu Z, et al. Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction[J/OL]. Cell Death Dis, 2017, 8(7): e2941[2017-07-20]. https://pubmed.ncbi.nlm.nih.gov/28726778/. DOI: 10.1038/cddis.2017.308.
|
11. |
Rezzola S, Belleri M, Gariano G, et al. In vitro and ex vivo retina angiogenesis assays[J]. Angiogenesis, 2014, 17(3): 429-442. DOI: 10.1007/s10456-013-9398-x.
|
12. |
Kong H, Zhao H, Chen T, et al. Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy[J]. Cell Death Dis, 2022, 13(4): 336. DOI: 10.1038/s41419-022-04786-w.
|
13. |
Watari K, Shibata T, Nabeshima H, et al. Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in NDRG1 deficient mice[J/OL]. Sci Rep, 2016, 6: 19470[2016-01-18]. https://pubmed.ncbi.nlm.nih.gov/26778110/. DOI: 10.1038/srep19470.
|
14. |
Li D, Mei H, Qi M, et al. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma[J]. Oncotarget, 2013, 4(11): 2021-2044. DOI: 10.18632/oncotarget.1579.
|
15. |
Zhang G, Qin Q, Zhang C, et al. NDRG1 signaling is essential for endothelial inflammation and vascular remodeling[J]. Circ Res, 2023, 132(3): 306-319. DOI: 10.1161/CIRCRESAHA.122.321837.
|
16. |
Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine[J/OL]. Cytokine, 2022, 153: 155828[2022-03-02]. https://pubmed.ncbi.nlm.nih.gov/35247648/. DOI: 10.1016/j.cyto.2022.155828.
|
17. |
Lai LC, Su YY, Chen KC, et al. Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation[J/OL]. PLoS One, 2011, 6(8): e24375[2011-08-30]. https://pubmed.ncbi.nlm.nih.gov/21912630/. DOI: 10.1371/journal.pone.0024375.
|
18. |
Zhao T, Meng Y, Wang Y, et al. NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation[J]. J Orthop Surg Res, 2021, 16(1): 364. DOI: 10.1186/s13018-021-02503-5.
|
19. |
Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances[J]. Sensors (Basel), 2018, 18(10): 3249. DOI: 10.3390/s18103249.
|
20. |
Wei M, Zhang Y, Yang X, et al. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription[J/OL]. Clin Transl Med, 2021, 11(12): e667[2021-12-01]. https://pubmed.ncbi.nlm.nih.gov/34965023/. DOI: 10.1002/ctm2.667.
|
21. |
Takita S, Wada Y, Kawamura S. Effects of NDRG1 family proteins on photoreceptor outer segment morphology in zebrafish[J/OL]. Sci Rep, 2016, 6: 36590[2016-11-04]. https://pubmed.ncbi.nlm.nih.gov/27811999/. DOI: 10.1038/srep36590.
|